FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms
AUTOR(ES)
Siewert, Martin
FONTE
Springer-Verlag
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2750303Documentos Relacionados
- Comparison of dissolution profile of extended-release oral dosage forms - two one-sided equivalence test
- Applications of USP apparatus 3 in assessing the in vitro release of solid oral dosage forms
- HPLC method development for the simultaneous analysis of amlodipine and valsartan in combined dosage forms and in vitro dissolution studies
- Announcing the AAPS 43rd annual pharmaceutical technologies arden conference: Particle and powder technologies for solid dosage forms
- Development and validation of spectroscopic methods for simultaneous estimation and dissolution of ofloxacin and ornidazole in tablet dosage forms